Advisory Board

Strategic and Business Advisors:

Joe Belanoff, M.D.
- CEO – Corcept Therapeutics
Perry Fell, Ph.D.
- President and CEO – NanoString Technologies, Inc.
- President and CEO – Seattle Genetics
- Director, Molecular Immunology – Bristol-Myers Squibb
Stephen Hilbert, M.B.A.
- Principal – The Rainier Group
- Vice President – JP Morgan Asset Management
Alan Leong, Ph.D., M.S.E.
- Director of Research – Biotech Stock Research
- Director – University of Washington Center for Commercialization
Randall Schatzman, Ph.D.
- CEO – Alder Biopharmaceuticals
Douglas Sanders, M.B.A.
- CFO – CMC Biologics A/S
- CFO and Head of Business Operations – Hoffmann-La Roche, Roche Consumer Health Division
- CFO – MediQuest Therapeutics

Collaborators:

Clinical and Regulatory Team:

Richard Chin, M.D.
- CEO – OneWorld Health
- CEO – Oxigene
- Head of Clinical Research – Genentech Biotherapeutics Unit
- Author of four books on clinical trials
Allene Dodge
- VP of Regulatory Affairs and Quality Assurance – Cell Therapeutics
- Sr. Dir. of Regulatory Affairs and Quality Assurance – CV Therapeutics
- Director of Regulatory Affairs – Genentech
Daniel F. Hoth, M.D.
- Director – Seattle Genetics
- Chief Medical Officer – Axys
- Chief Medical Officer – Gensys
- Director of AIDS Division – NIAID
- Chief of the Investigational Drug Branch – NCI
Donna Matuizek
- Sr. Regulatory Affairs Consultant – Harris Group
- Sr. Manager of Contract Manufacturing – Dendreon
- Director of Quality Control – Dendreon
Rick Stead, M.D.
- VP of Clinical Research – Immunex
- Medical Director – Amgen
- Had significant roles in the clinical development, FDA approval, and commercialization of Epogen® and Neupogen®
Joyce Frey-Vasconcells, Ph.D.
- Cell and Gene Therapy Regulatory Consulting
- Deputy Director Office of Cellular, Tissue, and Gene Therapies – FDA
- PharmNet Consulting

Scientific Advisors:

François-Loïc Cosset, Ph.D.
- Research Director, CNRS – Viral Envelopes & Retrovirus Engineering – Ecole Normale Supérieure (ENS) de Lyon
- Developed the novel lentiviral vector needed to transfect B lymphocytes
Iqbal Grewal, Ph.D., D.Sc., FRCPath (Pre-clinical Advisor)
- VP of Pre-clinical Development – Seattle Genetics
- Senior Scientist, Lab Head and Project Leader – Genentech
- Has brought more than 6 molecules to clinical development.
Shelly Heimfeld, Ph.D.
- Scientific Director for Cellular Therapy – Seattle Cancer Care Alliance
- Lab Director – Fred Hutchinson Cancer Research Center
Hans-Peter Kiem, M.D.
- José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research – Fred Hutchinson Cancer Research Center
- Member – Clinical Research Division, Fred Hutchinson Cancer Research Center
- Professor of Medicine – University of Washington School of Medicine
Xin M. Luo, Ph.D.
- Lead Researcher – Baltimore Lab, Caltech
- Developed systems for engineering immunity against HIV-1.
- Studies molecular control mechanisms of B-cell development.
Cliona Rooney, Ph.D.
- Investigator – clinical trial for the iCasp9 suicide gene system
- Expert in cellular immunotherapy

advisory board